Found: 26
Select item for more details and to access through your institution.
Risk Factors for Early Onset of Proteinuria in Patients Receiving Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 251, doi. 10.1159/000528145
- By:
- Publication type:
- Article
Pathological Complete Response to Lenvatinib after Failure of Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
The importance of body composition assessment for patients with advanced hepatocellular carcinoma by bioelectrical impedance analysis in lenvatinib treatment.
- Published in:
- PLoS ONE, 2022, v. 17, n. 1, p. 1, doi. 10.1371/journal.pone.0262675
- By:
- Publication type:
- Article
Successful Lenvatinib Re-challenge following Atezolizumab Plus Bevacizumab Combination Therapy Failure for Unresectable Hepatocellular Carcinoma.
- Published in:
- Internal Medicine, 2023, v. 62, n. 12, p. 1771, doi. 10.2169/internalmedicine.9581-22
- By:
- Publication type:
- Article
Comparison of hepatic arterial infusion chemotherapy between 5‐fluorouracil‐based continuous infusion chemotherapy and low‐dose cisplatin monotherapy for advanced hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2018, v. 48, n. 13, p. 1118, doi. 10.1111/hepr.13232
- By:
- Publication type:
- Article
Clinical outcomes of sorafenib treatment failure for advanced hepatocellular carcinoma and candidates for regorafenib treatment in real‐world practice.
- Published in:
- Hepatology Research, 2018, v. 48, n. 10, p. 814, doi. 10.1111/hepr.13180
- By:
- Publication type:
- Article
Clinical Outcomes of 2nd- and 3rd-Line Regorafenib for Advanced Hepatocellular Carcinoma.
- Published in:
- Oncology, 2021, v. 99, n. 8, p. 491, doi. 10.1159/000515280
- By:
- Publication type:
- Article
Analysis of Post-Progression Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib.
- Published in:
- Oncology, 2020, v. 98, n. 11, p. 787, doi. 10.1159/000509387
- By:
- Publication type:
- Article
Correlation between Early Tumor Marker Response and Imaging Response in Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib.
- Published in:
- Oncology, 2019, v. 97, n. 2, p. 75, doi. 10.1159/000499715
- By:
- Publication type:
- Article
Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis.
- Published in:
- Oncology, 2018, v. 94, n. 4, p. 215, doi. 10.1159/000486483
- By:
- Publication type:
- Article
Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02016-3
- By:
- Publication type:
- Article
Efficacy and safety of chemoradiation therapy using one-shot cisplatin via hepatic arterial infusion for advanced hepatocellular carcinoma with major macrovascular invasion: a single-arm retrospective cohort study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Early experience of seven hepatocellular carcinoma cases treated with regorafenib.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Early changes in ammonia levels and liver function in patients with advanced hepatocellular carcinoma treated by lenvatinib therapy.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-48045-z
- By:
- Publication type:
- Article
Benign Recurrent Intrahepatic Cholestasis Type 1 with Novel Nonsense Mutations in the ATP8B1 Gene.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Extracellular water to total body water ratio obtained by bioelectrical impedance analysis determines the dose intensity of lenvatinib for the treatment of patients with advanced hepatocellular carcinoma.
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 6, p. 1685, doi. 10.1111/jgh.15377
- By:
- Publication type:
- Article
Risk factors for histological progression of non‐alcoholic steatohepatitis analyzed from repeated biopsy cases.
- Published in:
- Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 8, p. 1412, doi. 10.1111/jgh.14968
- By:
- Publication type:
- Article
Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status.
- Published in:
- Journal of Gastroenterology & Hepatology, 2018, v. 33, n. 10, p. 1780, doi. 10.1111/jgh.14152
- By:
- Publication type:
- Article
Circulating cytokines and angiogenic factors based signature associated with the relative dose intensity during treatment in patients with advanced hepatocellular carcinoma receiving lenvatinib.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920922051
- By:
- Publication type:
- Article
Practical guidance for treatment of patients with diabetes using flash glucose monitoring: a pilot study.
- Published in:
- Diabetology & Metabolic Syndrome, 2018, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13098-018-0364-z
- By:
- Publication type:
- Article
Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 320, doi. 10.3390/cancers14020320
- By:
- Publication type:
- Article
Early Tumor Response and Safety of Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma in Real-World Practice.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 3958, doi. 10.3390/cancers13163958
- By:
- Publication type:
- Article
Calcium channel blockers improve the prognosis of patients with intrahepatic cholangiocarcinoma after resection.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Management of refractory ascites attenuates muscle mass reduction and improves survival in patients with decompensated cirrhosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Simultaneous Manifestation of Chronic Myelomonocytic Leukemia and Multiple Myeloma during Treatment by Prednisolone and Eltrombopag for Immune-Mediated Thrombocytopenic Purpura.
- Published in:
- Case Reports in Hematology, 2016, p. 1, doi. 10.1155/2016/4342820
- By:
- Publication type:
- Article
Impact and usefulness of the transition to the new MAFLD classification for non-B, non-C HCC: a retrospective cohort study.
- Published in:
- BMC Gastroenterology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12876-023-02851-y
- By:
- Publication type:
- Article